PharmaCom BioVet, Inc.
PharmaCom BioVet, Inc. (PHMB) Stock Competitors & Peer Comparison
See (PHMB) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| PHMB | $0.00 | +0.00% | 1.1M | N/A | N/A | N/A |
| FSNUY | $12.87 | +0.70% | 116.9B | 16.42 | $0.79 | +2.19% |
| FSNUF | $54.35 | +0.00% | 30.6B | 17.25 | $3.15 | +2.08% |
| JDHIY | $6.85 | +0.00% | 21.9B | 28.54 | $0.24 | N/A |
| JDHIF | $6.15 | +0.00% | 19.7B | 29.29 | $0.21 | N/A |
| IHHHF | $1.45 | +0.00% | 12.8B | 20.71 | $0.07 | +1.76% |
| FMCQF | $44.25 | -10.08% | 12.4B | 15.26 | $2.90 | +3.67% |
| BDULF | $0.66 | +0.00% | 10.5B | 22.00 | $0.03 | +4.59% |
| BDUUF | $0.65 | +0.00% | 10.3B | 21.67 | $0.03 | +4.66% |
| BDUUY | $20.42 | +0.00% | 8.1B | 16.74 | $1.22 | +4.63% |
Stock Comparison
PHMB vs FSNUY Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, FSNUY has a market cap of 116.9B. Regarding current trading prices, PHMB is priced at $0.00, while FSNUY trades at $12.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas FSNUY's P/E ratio is 16.42. In terms of profitability, PHMB's ROE is N/A, compared to FSNUY's ROE of +0.07%. Regarding short-term risk, PHMB is more volatile compared to FSNUY. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check FSNUY's competition here
PHMB vs FSNUF Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, FSNUF has a market cap of 30.6B. Regarding current trading prices, PHMB is priced at $0.00, while FSNUF trades at $54.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas FSNUF's P/E ratio is 17.25. In terms of profitability, PHMB's ROE is N/A, compared to FSNUF's ROE of +0.07%. Regarding short-term risk, PHMB is more volatile compared to FSNUF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check FSNUF's competition here
PHMB vs JDHIY Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, JDHIY has a market cap of 21.9B. Regarding current trading prices, PHMB is priced at $0.00, while JDHIY trades at $6.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas JDHIY's P/E ratio is 28.54. In terms of profitability, PHMB's ROE is N/A, compared to JDHIY's ROE of +0.09%. Regarding short-term risk, PHMB is more volatile compared to JDHIY. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check JDHIY's competition here
PHMB vs JDHIF Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, JDHIF has a market cap of 19.7B. Regarding current trading prices, PHMB is priced at $0.00, while JDHIF trades at $6.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas JDHIF's P/E ratio is 29.29. In terms of profitability, PHMB's ROE is N/A, compared to JDHIF's ROE of +0.09%. Regarding short-term risk, PHMB is more volatile compared to JDHIF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check JDHIF's competition here
PHMB vs IHHHF Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, IHHHF has a market cap of 12.8B. Regarding current trading prices, PHMB is priced at $0.00, while IHHHF trades at $1.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas IHHHF's P/E ratio is 20.71. In terms of profitability, PHMB's ROE is N/A, compared to IHHHF's ROE of +0.07%. Regarding short-term risk, PHMB is more volatile compared to IHHHF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check IHHHF's competition here
PHMB vs FMCQF Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, FMCQF has a market cap of 12.4B. Regarding current trading prices, PHMB is priced at $0.00, while FMCQF trades at $44.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas FMCQF's P/E ratio is 15.26. In terms of profitability, PHMB's ROE is N/A, compared to FMCQF's ROE of +0.07%. Regarding short-term risk, PHMB is more volatile compared to FMCQF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check FMCQF's competition here
PHMB vs BDULF Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, BDULF has a market cap of 10.5B. Regarding current trading prices, PHMB is priced at $0.00, while BDULF trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas BDULF's P/E ratio is 22.00. In terms of profitability, PHMB's ROE is N/A, compared to BDULF's ROE of +0.15%. Regarding short-term risk, PHMB is more volatile compared to BDULF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check BDULF's competition here
PHMB vs BDUUF Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, BDUUF has a market cap of 10.3B. Regarding current trading prices, PHMB is priced at $0.00, while BDUUF trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas BDUUF's P/E ratio is 21.67. In terms of profitability, PHMB's ROE is N/A, compared to BDUUF's ROE of +0.15%. Regarding short-term risk, PHMB is more volatile compared to BDUUF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check BDUUF's competition here
PHMB vs BDUUY Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, BDUUY has a market cap of 8.1B. Regarding current trading prices, PHMB is priced at $0.00, while BDUUY trades at $20.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas BDUUY's P/E ratio is 16.74. In terms of profitability, PHMB's ROE is N/A, compared to BDUUY's ROE of +0.15%. Regarding short-term risk, PHMB is more volatile compared to BDUUY. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check BDUUY's competition here
PHMB vs RMYHY Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, RMYHY has a market cap of 6.4B. Regarding current trading prices, PHMB is priced at $0.00, while RMYHY trades at $6.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas RMYHY's P/E ratio is 31.70. In terms of profitability, PHMB's ROE is N/A, compared to RMYHY's ROE of +0.06%. Regarding short-term risk, PHMB is more volatile compared to RMYHY. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check RMYHY's competition here
PHMB vs RMSYF Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, RMSYF has a market cap of 5.7B. Regarding current trading prices, PHMB is priced at $0.00, while RMSYF trades at $25.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas RMSYF's P/E ratio is 357.14. In terms of profitability, PHMB's ROE is N/A, compared to RMSYF's ROE of +0.06%. Regarding short-term risk, PHMB is more volatile compared to RMSYF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check RMSYF's competition here
PHMB vs BUHPF Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, BUHPF has a market cap of 4.5B. Regarding current trading prices, PHMB is priced at $0.00, while BUHPF trades at $5.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas BUHPF's P/E ratio is 20.93. In terms of profitability, PHMB's ROE is N/A, compared to BUHPF's ROE of +0.26%. Regarding short-term risk, PHMB is more volatile compared to BUHPF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check BUHPF's competition here
PHMB vs MCVEF Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, MCVEF has a market cap of 4.1B. Regarding current trading prices, PHMB is priced at $0.00, while MCVEF trades at $27.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas MCVEF's P/E ratio is 52.40. In terms of profitability, PHMB's ROE is N/A, compared to MCVEF's ROE of +0.16%. Regarding short-term risk, PHMB is more volatile compared to MCVEF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check MCVEF's competition here
PHMB vs ANHGY Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, ANHGY has a market cap of 4B. Regarding current trading prices, PHMB is priced at $0.00, while ANHGY trades at $5.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas ANHGY's P/E ratio is 23.87. In terms of profitability, PHMB's ROE is N/A, compared to ANHGY's ROE of N/A. Regarding short-term risk, PHMB is more volatile compared to ANHGY. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check ANHGY's competition here
PHMB vs BUGDF Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, BUGDF has a market cap of 3.8B. Regarding current trading prices, PHMB is priced at $0.00, while BUGDF trades at $4.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas BUGDF's P/E ratio is 16.96. In terms of profitability, PHMB's ROE is N/A, compared to BUGDF's ROE of +0.26%. Regarding short-term risk, PHMB is more volatile compared to BUGDF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check BUGDF's competition here
PHMB vs MCVEY Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, MCVEY has a market cap of 2.5B. Regarding current trading prices, PHMB is priced at $0.00, while MCVEY trades at $16.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas MCVEY's P/E ratio is 40.37. In terms of profitability, PHMB's ROE is N/A, compared to MCVEY's ROE of +0.14%. Regarding short-term risk, PHMB is more volatile compared to MCVEY. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check MCVEY's competition here
PHMB vs ORPEF Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, ORPEF has a market cap of 2.3B. Regarding current trading prices, PHMB is priced at $0.00, while ORPEF trades at $14.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas ORPEF's P/E ratio is 0.03. In terms of profitability, PHMB's ROE is N/A, compared to ORPEF's ROE of -0.13%. Regarding short-term risk, PHMB is less volatile compared to ORPEF. This indicates potentially lower risk in terms of short-term price fluctuations for PHMB.Check ORPEF's competition here
PHMB vs EXETF Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, EXETF has a market cap of 1.8B. Regarding current trading prices, PHMB is priced at $0.00, while EXETF trades at $18.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas EXETF's P/E ratio is 23.33. In terms of profitability, PHMB's ROE is N/A, compared to EXETF's ROE of +0.48%. Regarding short-term risk, PHMB is more volatile compared to EXETF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check EXETF's competition here
PHMB vs LWSCF Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, LWSCF has a market cap of 1.6B. Regarding current trading prices, PHMB is priced at $0.00, while LWSCF trades at $15.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas LWSCF's P/E ratio is 44.91. In terms of profitability, PHMB's ROE is N/A, compared to LWSCF's ROE of +0.07%. Regarding short-term risk, PHMB is more volatile compared to LWSCF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check LWSCF's competition here
PHMB vs RAFLF Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, RAFLF has a market cap of 1.5B. Regarding current trading prices, PHMB is priced at $0.00, while RAFLF trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas RAFLF's P/E ratio is 26.67. In terms of profitability, PHMB's ROE is N/A, compared to RAFLF's ROE of +0.05%. Regarding short-term risk, PHMB is more volatile compared to RAFLF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check RAFLF's competition here
PHMB vs RHCGF Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, RHCGF has a market cap of 1.4B. Regarding current trading prices, PHMB is priced at $0.00, while RHCGF trades at $1.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas RHCGF's P/E ratio is -5.04. In terms of profitability, PHMB's ROE is N/A, compared to RHCGF's ROE of -0.14%. Regarding short-term risk, PHMB is more volatile compared to RHCGF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check RHCGF's competition here
PHMB vs TTALF Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, TTALF has a market cap of 1.1B. Regarding current trading prices, PHMB is priced at $0.00, while TTALF trades at $8.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas TTALF's P/E ratio is 10.65. In terms of profitability, PHMB's ROE is N/A, compared to TTALF's ROE of +0.16%. Regarding short-term risk, PHMB is more volatile compared to TTALF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check TTALF's competition here
PHMB vs RKAGY Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, RKAGY has a market cap of 1.1B. Regarding current trading prices, PHMB is priced at $0.00, while RKAGY trades at $8.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas RKAGY's P/E ratio is 24.73. In terms of profitability, PHMB's ROE is N/A, compared to RKAGY's ROE of +0.03%. Regarding short-term risk, PHMB is more volatile compared to RKAGY. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check RKAGY's competition here
PHMB vs RYHTY Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, RYHTY has a market cap of 1.1B. Regarding current trading prices, PHMB is priced at $0.00, while RYHTY trades at $6.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas RYHTY's P/E ratio is -4.59. In terms of profitability, PHMB's ROE is N/A, compared to RYHTY's ROE of -0.14%. Regarding short-term risk, PHMB is more volatile compared to RYHTY. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check RYHTY's competition here
PHMB vs RHKJF Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, RHKJF has a market cap of 1B. Regarding current trading prices, PHMB is priced at $0.00, while RHKJF trades at $15.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas RHKJF's P/E ratio is 21.55. In terms of profitability, PHMB's ROE is N/A, compared to RHKJF's ROE of +0.03%. Regarding short-term risk, PHMB is more volatile compared to RHKJF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check RHKJF's competition here
PHMB vs LTGHY Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, LTGHY has a market cap of 1B. Regarding current trading prices, PHMB is priced at $0.00, while LTGHY trades at $2.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas LTGHY's P/E ratio is -11.08. In terms of profitability, PHMB's ROE is N/A, compared to LTGHY's ROE of +0.38%. Regarding short-term risk, PHMB is more volatile compared to LTGHY. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check LTGHY's competition here
PHMB vs LTGHF Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, LTGHF has a market cap of 978.7M. Regarding current trading prices, PHMB is priced at $0.00, while LTGHF trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas LTGHF's P/E ratio is -11.40. In terms of profitability, PHMB's ROE is N/A, compared to LTGHF's ROE of +8.48%. Regarding short-term risk, PHMB is more volatile compared to LTGHF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check LTGHF's competition here
PHMB vs NWKHY Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, NWKHY has a market cap of 854.5M. Regarding current trading prices, PHMB is priced at $0.00, while NWKHY trades at $7.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas NWKHY's P/E ratio is 10.39. In terms of profitability, PHMB's ROE is N/A, compared to NWKHY's ROE of +0.16%. Regarding short-term risk, PHMB is more volatile compared to NWKHY. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check NWKHY's competition here
PHMB vs JXFGF Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, JXFGF has a market cap of 782.5M. Regarding current trading prices, PHMB is priced at $0.00, while JXFGF trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas JXFGF's P/E ratio is -5.80. In terms of profitability, PHMB's ROE is N/A, compared to JXFGF's ROE of -0.11%. Regarding short-term risk, PHMB is more volatile compared to JXFGF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check JXFGF's competition here
PHMB vs WHTCF Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, WHTCF has a market cap of 696M. Regarding current trading prices, PHMB is priced at $0.00, while WHTCF trades at $2.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas WHTCF's P/E ratio is -136.22. In terms of profitability, PHMB's ROE is N/A, compared to WHTCF's ROE of -0.06%. Regarding short-term risk, PHMB is more volatile compared to WHTCF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check WHTCF's competition here
PHMB vs KDGTF Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, KDGTF has a market cap of 675.1M. Regarding current trading prices, PHMB is priced at $0.00, while KDGTF trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas KDGTF's P/E ratio is -1.67. In terms of profitability, PHMB's ROE is N/A, compared to KDGTF's ROE of N/A. Regarding short-term risk, PHMB is more volatile compared to KDGTF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check KDGTF's competition here
PHMB vs WFHG Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, WFHG has a market cap of 476.9M. Regarding current trading prices, PHMB is priced at $0.00, while WFHG trades at $7.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas WFHG's P/E ratio is N/A. In terms of profitability, PHMB's ROE is N/A, compared to WFHG's ROE of +0.00%. Regarding short-term risk, PHMB is more volatile compared to WFHG. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check WFHG's competition here
PHMB vs ORRRY Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, ORRRY has a market cap of 371.5M. Regarding current trading prices, PHMB is priced at $0.00, while ORRRY trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas ORRRY's P/E ratio is -0.33. In terms of profitability, PHMB's ROE is N/A, compared to ORRRY's ROE of +7.04%. Regarding short-term risk, PHMB is more volatile compared to ORRRY. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check ORRRY's competition here
PHMB vs BTMDW Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, BTMDW has a market cap of 292.9M. Regarding current trading prices, PHMB is priced at $0.00, while BTMDW trades at $1.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas BTMDW's P/E ratio is 0.05. In terms of profitability, PHMB's ROE is N/A, compared to BTMDW's ROE of -0.35%. Regarding short-term risk, PHMB is more volatile compared to BTMDW. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check BTMDW's competition here
PHMB vs MFCSF Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, MFCSF has a market cap of 219.1M. Regarding current trading prices, PHMB is priced at $0.00, while MFCSF trades at $11.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas MFCSF's P/E ratio is 15.06. In terms of profitability, PHMB's ROE is N/A, compared to MFCSF's ROE of +0.27%. Regarding short-term risk, PHMB is more volatile compared to MFCSF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check MFCSF's competition here
PHMB vs MKLNF Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, MKLNF has a market cap of 214.8M. Regarding current trading prices, PHMB is priced at $0.00, while MKLNF trades at $11.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas MKLNF's P/E ratio is 19.23. In terms of profitability, PHMB's ROE is N/A, compared to MKLNF's ROE of +0.16%. Regarding short-term risk, PHMB is more volatile compared to MKLNF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check MKLNF's competition here
PHMB vs CHHHF Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, CHHHF has a market cap of 165.6M. Regarding current trading prices, PHMB is priced at $0.00, while CHHHF trades at $2.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas CHHHF's P/E ratio is 8.80. In terms of profitability, PHMB's ROE is N/A, compared to CHHHF's ROE of +0.28%. Regarding short-term risk, PHMB is more volatile compared to CHHHF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check CHHHF's competition here
PHMB vs HWAIF Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, HWAIF has a market cap of 160.6M. Regarding current trading prices, PHMB is priced at $0.00, while HWAIF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas HWAIF's P/E ratio is -4.98. In terms of profitability, PHMB's ROE is N/A, compared to HWAIF's ROE of -0.39%. Regarding short-term risk, PHMB is more volatile compared to HWAIF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check HWAIF's competition here
PHMB vs COLRF Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, COLRF has a market cap of 123M. Regarding current trading prices, PHMB is priced at $0.00, while COLRF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas COLRF's P/E ratio is -8.00. In terms of profitability, PHMB's ROE is N/A, compared to COLRF's ROE of +0.00%. Regarding short-term risk, PHMB is less volatile compared to COLRF. This indicates potentially lower risk in terms of short-term price fluctuations for PHMB.Check COLRF's competition here
PHMB vs VTIAF Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, VTIAF has a market cap of 111.1M. Regarding current trading prices, PHMB is priced at $0.00, while VTIAF trades at $6.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas VTIAF's P/E ratio is -9.11. In terms of profitability, PHMB's ROE is N/A, compared to VTIAF's ROE of -0.71%. Regarding short-term risk, PHMB is more volatile compared to VTIAF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check VTIAF's competition here
PHMB vs TOKIF Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, TOKIF has a market cap of 101.4M. Regarding current trading prices, PHMB is priced at $0.00, while TOKIF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas TOKIF's P/E ratio is -0.57. In terms of profitability, PHMB's ROE is N/A, compared to TOKIF's ROE of -0.83%. Regarding short-term risk, PHMB is less volatile compared to TOKIF. This indicates potentially lower risk in terms of short-term price fluctuations for PHMB.Check TOKIF's competition here
PHMB vs NAFS Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, NAFS has a market cap of 59.6M. Regarding current trading prices, PHMB is priced at $0.00, while NAFS trades at $0.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas NAFS's P/E ratio is N/A. In terms of profitability, PHMB's ROE is N/A, compared to NAFS's ROE of +0.31%. Regarding short-term risk, PHMB is more volatile compared to NAFS. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check NAFS's competition here
PHMB vs MCIOF Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, MCIOF has a market cap of 54M. Regarding current trading prices, PHMB is priced at $0.00, while MCIOF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas MCIOF's P/E ratio is -1.22. In terms of profitability, PHMB's ROE is N/A, compared to MCIOF's ROE of N/A. Regarding short-term risk, PHMB is more volatile compared to MCIOF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check MCIOF's competition here
PHMB vs ASSF Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, ASSF has a market cap of 45.3M. Regarding current trading prices, PHMB is priced at $0.00, while ASSF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas ASSF's P/E ratio is -33.33. In terms of profitability, PHMB's ROE is N/A, compared to ASSF's ROE of -6.63%. Regarding short-term risk, PHMB is more volatile compared to ASSF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check ASSF's competition here
PHMB vs NVLPF Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, NVLPF has a market cap of 22.4M. Regarding current trading prices, PHMB is priced at $0.00, while NVLPF trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas NVLPF's P/E ratio is 25.68. In terms of profitability, PHMB's ROE is N/A, compared to NVLPF's ROE of -0.01%. Regarding short-term risk, PHMB is more volatile compared to NVLPF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check NVLPF's competition here
PHMB vs USNU Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, USNU has a market cap of 22.2M. Regarding current trading prices, PHMB is priced at $0.00, while USNU trades at $1.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas USNU's P/E ratio is -9.41. In terms of profitability, PHMB's ROE is N/A, compared to USNU's ROE of -0.71%. Regarding short-term risk, PHMB is more volatile compared to USNU. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check USNU's competition here
PHMB vs HQDA Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, HQDA has a market cap of 18.6M. Regarding current trading prices, PHMB is priced at $0.00, while HQDA trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas HQDA's P/E ratio is N/A. In terms of profitability, PHMB's ROE is N/A, compared to HQDA's ROE of -0.06%. Regarding short-term risk, PHMB is more volatile compared to HQDA. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check HQDA's competition here
PHMB vs GBCS Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, GBCS has a market cap of 12.9M. Regarding current trading prices, PHMB is priced at $0.00, while GBCS trades at $4.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas GBCS's P/E ratio is -15.00. In terms of profitability, PHMB's ROE is N/A, compared to GBCS's ROE of +0.13%. Regarding short-term risk, PHMB is more volatile compared to GBCS. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check GBCS's competition here
PHMB vs EVGRF Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, EVGRF has a market cap of 11.9M. Regarding current trading prices, PHMB is priced at $0.00, while EVGRF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas EVGRF's P/E ratio is N/A. In terms of profitability, PHMB's ROE is N/A, compared to EVGRF's ROE of +0.22%. Regarding short-term risk, PHMB is more volatile compared to EVGRF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check EVGRF's competition here
PHMB vs FPCG Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, FPCG has a market cap of 10.1M. Regarding current trading prices, PHMB is priced at $0.00, while FPCG trades at $1,025.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas FPCG's P/E ratio is 0.09. In terms of profitability, PHMB's ROE is N/A, compared to FPCG's ROE of +0.00%. Regarding short-term risk, PHMB is more volatile compared to FPCG. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check FPCG's competition here
PHMB vs HLYK Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, HLYK has a market cap of 8.1M. Regarding current trading prices, PHMB is priced at $0.00, while HLYK trades at $3.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas HLYK's P/E ratio is -2.39. In terms of profitability, PHMB's ROE is N/A, compared to HLYK's ROE of +0.88%. Regarding short-term risk, PHMB is more volatile compared to HLYK. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check HLYK's competition here
PHMB vs BICX Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, BICX has a market cap of 7.6M. Regarding current trading prices, PHMB is priced at $0.00, while BICX trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas BICX's P/E ratio is -1.25. In terms of profitability, PHMB's ROE is N/A, compared to BICX's ROE of +0.41%. Regarding short-term risk, PHMB is more volatile compared to BICX. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check BICX's competition here
PHMB vs RVLWF Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, RVLWF has a market cap of 5.4M. Regarding current trading prices, PHMB is priced at $0.00, while RVLWF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas RVLWF's P/E ratio is -0.30. In terms of profitability, PHMB's ROE is N/A, compared to RVLWF's ROE of +3.95%. Regarding short-term risk, PHMB is more volatile compared to RVLWF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check RVLWF's competition here
PHMB vs NUMIF Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, NUMIF has a market cap of 4M. Regarding current trading prices, PHMB is priced at $0.00, while NUMIF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas NUMIF's P/E ratio is -0.41. In terms of profitability, PHMB's ROE is N/A, compared to NUMIF's ROE of +11.51%. Regarding short-term risk, PHMB is more volatile compared to NUMIF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check NUMIF's competition here
PHMB vs VLXC Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, VLXC has a market cap of 3.9M. Regarding current trading prices, PHMB is priced at $0.00, while VLXC trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas VLXC's P/E ratio is -4.00. In terms of profitability, PHMB's ROE is N/A, compared to VLXC's ROE of +0.74%. Regarding short-term risk, PHMB is more volatile compared to VLXC. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check VLXC's competition here
PHMB vs XCRT Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, XCRT has a market cap of 3.6M. Regarding current trading prices, PHMB is priced at $0.00, while XCRT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas XCRT's P/E ratio is N/A. In terms of profitability, PHMB's ROE is N/A, compared to XCRT's ROE of +0.26%. Regarding short-term risk, PHMB is more volatile compared to XCRT. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check XCRT's competition here
PHMB vs RHEP Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, RHEP has a market cap of 2.9M. Regarding current trading prices, PHMB is priced at $0.00, while RHEP trades at $1.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas RHEP's P/E ratio is -7.53. In terms of profitability, PHMB's ROE is N/A, compared to RHEP's ROE of -0.04%. Regarding short-term risk, PHMB is more volatile compared to RHEP. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check RHEP's competition here
PHMB vs EPWCF Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, EPWCF has a market cap of 2.5M. Regarding current trading prices, PHMB is priced at $0.00, while EPWCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas EPWCF's P/E ratio is -0.00. In terms of profitability, PHMB's ROE is N/A, compared to EPWCF's ROE of +0.00%. Regarding short-term risk, PHMB and EPWCF have similar daily volatility (196.04).Check EPWCF's competition here
PHMB vs NRPR Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, NRPR has a market cap of 2.1M. Regarding current trading prices, PHMB is priced at $0.00, while NRPR trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas NRPR's P/E ratio is -0.03. In terms of profitability, PHMB's ROE is N/A, compared to NRPR's ROE of N/A. Regarding short-term risk, PHMB is more volatile compared to NRPR. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check NRPR's competition here
PHMB vs GRST Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, GRST has a market cap of 1.5M. Regarding current trading prices, PHMB is priced at $0.00, while GRST trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas GRST's P/E ratio is N/A. In terms of profitability, PHMB's ROE is N/A, compared to GRST's ROE of +0.17%. Regarding short-term risk, PHMB is more volatile compared to GRST. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check GRST's competition here
PHMB vs KJFI Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, KJFI has a market cap of 1.5M. Regarding current trading prices, PHMB is priced at $0.00, while KJFI trades at $0.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas KJFI's P/E ratio is -0.06. In terms of profitability, PHMB's ROE is N/A, compared to KJFI's ROE of +0.00%. Regarding short-term risk, PHMB is more volatile compared to KJFI. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check KJFI's competition here
PHMB vs SMAS Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, SMAS has a market cap of 1.5M. Regarding current trading prices, PHMB is priced at $0.00, while SMAS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas SMAS's P/E ratio is N/A. In terms of profitability, PHMB's ROE is N/A, compared to SMAS's ROE of N/A. Regarding short-term risk, PHMB and SMAS have similar daily volatility (196.04).Check SMAS's competition here
PHMB vs MDGP Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, MDGP has a market cap of 1.5M. Regarding current trading prices, PHMB is priced at $0.00, while MDGP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas MDGP's P/E ratio is N/A. In terms of profitability, PHMB's ROE is N/A, compared to MDGP's ROE of -2.19%. Regarding short-term risk, PHMB is more volatile compared to MDGP. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check MDGP's competition here
PHMB vs MAHN Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, MAHN has a market cap of 1.3M. Regarding current trading prices, PHMB is priced at $0.00, while MAHN trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas MAHN's P/E ratio is 55.00. In terms of profitability, PHMB's ROE is N/A, compared to MAHN's ROE of N/A. Regarding short-term risk, PHMB is more volatile compared to MAHN. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check MAHN's competition here
PHMB vs NOVC Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, NOVC has a market cap of 1.2M. Regarding current trading prices, PHMB is priced at $0.00, while NOVC trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas NOVC's P/E ratio is -0.20. In terms of profitability, PHMB's ROE is N/A, compared to NOVC's ROE of +0.12%. Regarding short-term risk, PHMB is more volatile compared to NOVC. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check NOVC's competition here
PHMB vs JRSS Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, JRSS has a market cap of 1.1M. Regarding current trading prices, PHMB is priced at $0.00, while JRSS trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas JRSS's P/E ratio is -0.13. In terms of profitability, PHMB's ROE is N/A, compared to JRSS's ROE of -0.09%. Regarding short-term risk, PHMB is more volatile compared to JRSS. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check JRSS's competition here
PHMB vs DPAT Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, DPAT has a market cap of 1.1M. Regarding current trading prices, PHMB is priced at $0.00, while DPAT trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas DPAT's P/E ratio is -2.25. In terms of profitability, PHMB's ROE is N/A, compared to DPAT's ROE of +0.45%. Regarding short-term risk, PHMB is more volatile compared to DPAT. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check DPAT's competition here
PHMB vs GNOW Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, GNOW has a market cap of 859.7K. Regarding current trading prices, PHMB is priced at $0.00, while GNOW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas GNOW's P/E ratio is -0.01. In terms of profitability, PHMB's ROE is N/A, compared to GNOW's ROE of -12.49%. Regarding short-term risk, PHMB is more volatile compared to GNOW. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check GNOW's competition here
PHMB vs MSITF Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, MSITF has a market cap of 480K. Regarding current trading prices, PHMB is priced at $0.00, while MSITF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas MSITF's P/E ratio is -0.10. In terms of profitability, PHMB's ROE is N/A, compared to MSITF's ROE of N/A. Regarding short-term risk, PHMB and MSITF have similar daily volatility (196.04).Check MSITF's competition here
PHMB vs ARPC Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, ARPC has a market cap of 336.6K. Regarding current trading prices, PHMB is priced at $0.00, while ARPC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas ARPC's P/E ratio is N/A. In terms of profitability, PHMB's ROE is N/A, compared to ARPC's ROE of +3.10%. Regarding short-term risk, PHMB is more volatile compared to ARPC. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check ARPC's competition here
PHMB vs NXGT Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, NXGT has a market cap of 292.2K. Regarding current trading prices, PHMB is priced at $0.00, while NXGT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas NXGT's P/E ratio is N/A. In terms of profitability, PHMB's ROE is N/A, compared to NXGT's ROE of +0.04%. Regarding short-term risk, PHMB is more volatile compared to NXGT. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check NXGT's competition here
PHMB vs BNYN Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, BNYN has a market cap of 286K. Regarding current trading prices, PHMB is priced at $0.00, while BNYN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas BNYN's P/E ratio is N/A. In terms of profitability, PHMB's ROE is N/A, compared to BNYN's ROE of -14.10%. Regarding short-term risk, PHMB is less volatile compared to BNYN. This indicates potentially lower risk in terms of short-term price fluctuations for PHMB.Check BNYN's competition here
PHMB vs SETO Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, SETO has a market cap of 234.5K. Regarding current trading prices, PHMB is priced at $0.00, while SETO trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas SETO's P/E ratio is -1.88. In terms of profitability, PHMB's ROE is N/A, compared to SETO's ROE of -123.80%. Regarding short-term risk, PHMB is more volatile compared to SETO. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check SETO's competition here
PHMB vs FCHS Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, FCHS has a market cap of 131.8K. Regarding current trading prices, PHMB is priced at $0.00, while FCHS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas FCHS's P/E ratio is -0.04. In terms of profitability, PHMB's ROE is N/A, compared to FCHS's ROE of +0.20%. Regarding short-term risk, PHMB is more volatile compared to FCHS. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check FCHS's competition here
PHMB vs TPIA Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, TPIA has a market cap of 113.8K. Regarding current trading prices, PHMB is priced at $0.00, while TPIA trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas TPIA's P/E ratio is -0.15. In terms of profitability, PHMB's ROE is N/A, compared to TPIA's ROE of +0.55%. Regarding short-term risk, PHMB is more volatile compared to TPIA. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check TPIA's competition here
PHMB vs AMBD Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, AMBD has a market cap of 85.6K. Regarding current trading prices, PHMB is priced at $0.00, while AMBD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas AMBD's P/E ratio is N/A. In terms of profitability, PHMB's ROE is N/A, compared to AMBD's ROE of +1.11%. Regarding short-term risk, PHMB and AMBD have similar daily volatility (196.04).Check AMBD's competition here
PHMB vs JNHMF Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, JNHMF has a market cap of 69.7K. Regarding current trading prices, PHMB is priced at $0.00, while JNHMF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas JNHMF's P/E ratio is -0.01. In terms of profitability, PHMB's ROE is N/A, compared to JNHMF's ROE of -3.60%. Regarding short-term risk, PHMB is more volatile compared to JNHMF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check JNHMF's competition here
PHMB vs NMHLY Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, NMHLY has a market cap of 41.7K. Regarding current trading prices, PHMB is priced at $0.00, while NMHLY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas NMHLY's P/E ratio is 0.02. In terms of profitability, PHMB's ROE is N/A, compared to NMHLY's ROE of N/A. Regarding short-term risk, PHMB is more volatile compared to NMHLY. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check NMHLY's competition here
PHMB vs CLRD Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, CLRD has a market cap of 28.8K. Regarding current trading prices, PHMB is priced at $0.00, while CLRD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas CLRD's P/E ratio is -0.01. In terms of profitability, PHMB's ROE is N/A, compared to CLRD's ROE of +0.38%. Regarding short-term risk, PHMB is more volatile compared to CLRD. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check CLRD's competition here
PHMB vs MSGP Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, MSGP has a market cap of 26K. Regarding current trading prices, PHMB is priced at $0.00, while MSGP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas MSGP's P/E ratio is N/A. In terms of profitability, PHMB's ROE is N/A, compared to MSGP's ROE of +0.27%. Regarding short-term risk, PHMB is more volatile compared to MSGP. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check MSGP's competition here
PHMB vs DRWN Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, DRWN has a market cap of 24K. Regarding current trading prices, PHMB is priced at $0.00, while DRWN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas DRWN's P/E ratio is N/A. In terms of profitability, PHMB's ROE is N/A, compared to DRWN's ROE of -0.01%. Regarding short-term risk, PHMB is more volatile compared to DRWN. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check DRWN's competition here
PHMB vs HSMD Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, HSMD has a market cap of 18.4K. Regarding current trading prices, PHMB is priced at $0.00, while HSMD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas HSMD's P/E ratio is -0.01. In terms of profitability, PHMB's ROE is N/A, compared to HSMD's ROE of -0.04%. Regarding short-term risk, PHMB is more volatile compared to HSMD. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check HSMD's competition here
PHMB vs SCAL Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, SCAL has a market cap of 17.4K. Regarding current trading prices, PHMB is priced at $0.00, while SCAL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas SCAL's P/E ratio is 0.04. In terms of profitability, PHMB's ROE is N/A, compared to SCAL's ROE of +0.07%. Regarding short-term risk, PHMB is more volatile compared to SCAL. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check SCAL's competition here
PHMB vs CEVE Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, CEVE has a market cap of 17.1K. Regarding current trading prices, PHMB is priced at $0.00, while CEVE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas CEVE's P/E ratio is N/A. In terms of profitability, PHMB's ROE is N/A, compared to CEVE's ROE of +2.26%. Regarding short-term risk, PHMB is more volatile compared to CEVE. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check CEVE's competition here
PHMB vs PRMD Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, PRMD has a market cap of 12.9K. Regarding current trading prices, PHMB is priced at $0.00, while PRMD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas PRMD's P/E ratio is N/A. In terms of profitability, PHMB's ROE is N/A, compared to PRMD's ROE of +0.73%. Regarding short-term risk, PHMB is more volatile compared to PRMD. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check PRMD's competition here
PHMB vs GENN Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, GENN has a market cap of 12.1K. Regarding current trading prices, PHMB is priced at $0.00, while GENN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas GENN's P/E ratio is -0.01. In terms of profitability, PHMB's ROE is N/A, compared to GENN's ROE of +0.07%. Regarding short-term risk, PHMB is more volatile compared to GENN. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check GENN's competition here
PHMB vs CHCR Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, CHCR has a market cap of 12K. Regarding current trading prices, PHMB is priced at $0.00, while CHCR trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas CHCR's P/E ratio is -0.00. In terms of profitability, PHMB's ROE is N/A, compared to CHCR's ROE of N/A. Regarding short-term risk, PHMB is more volatile compared to CHCR. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check CHCR's competition here
PHMB vs ACGI Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, ACGI has a market cap of 10.5K. Regarding current trading prices, PHMB is priced at $0.00, while ACGI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas ACGI's P/E ratio is N/A. In terms of profitability, PHMB's ROE is N/A, compared to ACGI's ROE of +1.11%. Regarding short-term risk, PHMB is more volatile compared to ACGI. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check ACGI's competition here
PHMB vs WEQL Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, WEQL has a market cap of 7.2K. Regarding current trading prices, PHMB is priced at $0.00, while WEQL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas WEQL's P/E ratio is N/A. In terms of profitability, PHMB's ROE is N/A, compared to WEQL's ROE of +0.21%. Regarding short-term risk, PHMB is more volatile compared to WEQL. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check WEQL's competition here
PHMB vs PAOG Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, PAOG has a market cap of 5K. Regarding current trading prices, PHMB is priced at $0.00, while PAOG trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas PAOG's P/E ratio is N/A. In terms of profitability, PHMB's ROE is N/A, compared to PAOG's ROE of +0.03%. Regarding short-term risk, PHMB is more volatile compared to PAOG. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check PAOG's competition here
PHMB vs SLHGF Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, SLHGF has a market cap of 4K. Regarding current trading prices, PHMB is priced at $0.00, while SLHGF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas SLHGF's P/E ratio is N/A. In terms of profitability, PHMB's ROE is N/A, compared to SLHGF's ROE of -0.42%. Regarding short-term risk, PHMB is more volatile compared to SLHGF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check SLHGF's competition here
PHMB vs SLHPF Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, SLHPF has a market cap of 3.9K. Regarding current trading prices, PHMB is priced at $0.00, while SLHPF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas SLHPF's P/E ratio is N/A. In terms of profitability, PHMB's ROE is N/A, compared to SLHPF's ROE of -0.42%. Regarding short-term risk, PHMB and SLHPF have similar daily volatility (196.04).Check SLHPF's competition here
PHMB vs ERUC Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, ERUC has a market cap of 3.9K. Regarding current trading prices, PHMB is priced at $0.00, while ERUC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas ERUC's P/E ratio is N/A. In terms of profitability, PHMB's ROE is N/A, compared to ERUC's ROE of N/A. Regarding short-term risk, PHMB is more volatile compared to ERUC. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check ERUC's competition here
PHMB vs BBAL Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, BBAL has a market cap of 3.4K. Regarding current trading prices, PHMB is priced at $0.00, while BBAL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas BBAL's P/E ratio is N/A. In terms of profitability, PHMB's ROE is N/A, compared to BBAL's ROE of +0.45%. Regarding short-term risk, PHMB is more volatile compared to BBAL. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check BBAL's competition here
PHMB vs NMMCF Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, NMMCF has a market cap of 2.1K. Regarding current trading prices, PHMB is priced at $0.00, while NMMCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas NMMCF's P/E ratio is N/A. In terms of profitability, PHMB's ROE is N/A, compared to NMMCF's ROE of +0.21%. Regarding short-term risk, PHMB is more volatile compared to NMMCF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check NMMCF's competition here
PHMB vs PPRG Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, PPRG has a market cap of 1.6K. Regarding current trading prices, PHMB is priced at $0.00, while PPRG trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas PPRG's P/E ratio is N/A. In terms of profitability, PHMB's ROE is N/A, compared to PPRG's ROE of -0.58%. Regarding short-term risk, PHMB is more volatile compared to PPRG. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check PPRG's competition here
PHMB vs KONEF Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, KONEF has a market cap of 1.6K. Regarding current trading prices, PHMB is priced at $0.00, while KONEF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas KONEF's P/E ratio is N/A. In terms of profitability, PHMB's ROE is N/A, compared to KONEF's ROE of -6.56%. Regarding short-term risk, PHMB is more volatile compared to KONEF. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check KONEF's competition here
PHMB vs OHAQ Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, OHAQ has a market cap of 1.4K. Regarding current trading prices, PHMB is priced at $0.00, while OHAQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas OHAQ's P/E ratio is 0.01. In terms of profitability, PHMB's ROE is N/A, compared to OHAQ's ROE of +0.09%. Regarding short-term risk, PHMB is more volatile compared to OHAQ. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check OHAQ's competition here
PHMB vs BNKL Comparison April 2026
PHMB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHMB stands at 1.1M. In comparison, BNKL has a market cap of 1.2K. Regarding current trading prices, PHMB is priced at $0.00, while BNKL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHMB currently has a P/E ratio of N/A, whereas BNKL's P/E ratio is N/A. In terms of profitability, PHMB's ROE is N/A, compared to BNKL's ROE of -7.69%. Regarding short-term risk, PHMB is more volatile compared to BNKL. This indicates potentially higher risk in terms of short-term price fluctuations for PHMB.Check BNKL's competition here